Read More Analyst Ratings News Price Target Barclays Maintains Overweight on Oportun Financial, Lowers Price Target to $7 By Benzinga Newsdesk October 13, 7:15 AM Barclays analyst Mark Devries maintains Oportun Financial (NASDAQ:OPRT) with a Overweight and lowers the price target from $12 to $7. OPRT
Read More News Offerings China Jo-Jo Drugstores Announces $2.59M Registered Direct Offering Of 9.96M Shares Of Stock At A Price Of $0.26/Share By Benzinga Newsdesk September 26, 9:25 AM China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in CJJD
Read More Analyst Ratings Downgrades News Raymond James Downgrades C.H. Robinson Worldwide to Underperform By Benzinga Newsdesk November 15, 7:35 AM Raymond James analyst Felix Boeschen downgrades C.H. Robinson Worldwide (NASDAQ:CHRW) from Market Perform to Underperform. CHRW
Read More Analyst Ratings News Price Target Morgan Stanley Maintains Equal-Weight on Jackson Finl, Lowers Price Target to $31 By Benzinga Newsdesk August 10, 9:39 AM Morgan Stanley analyst Nigel Dally maintains Jackson Finl (NYSE:JXN) with a Equal-Weight and lowers the price target from $33 to $31. JXN